Global prevalence of H. pylori infection has steadily declined over 40 years

by The University of Hong KongAlteration of core, common, and unique viruses after H. pylori eradication therapy. a Boxplots show the comparison of richness of viral species at each prevalence le

Updated on: February 19,2024

Global prevalence of H. pylori infection has steadily declined over 40 years

by The University of Hong KongAlteration of core, common, and unique viruses after H. pylori eradication therapy. a Boxplots show the comparison of richness of viral species at each prevalence le

Updated on:February 19,2024

Appetite linked to healthier gut bacteria in over-60s

by King's College LondonCredit: Unsplash/CC0 Public DomainOver-60s with a good appetite have more diverse and different communities of microbes in their gut than those with a poor appetite, a

Updated on: February 19,2024

Appetite linked to healthier gut bacteria in over-60s

by King's College LondonCredit: Unsplash/CC0 Public DomainOver-60s with a good appetite have more diverse and different communities of microbes in their gut than those with a poor appetite, a

Updated on:February 19,2024

AGA recommends bidirectional endoscopy for most patients with iron deficiency anemia

by American Gastroenterological AssociationCredit: Pixabay/CC0 Public DomainThe American Gastroenterological Association (AGA) published new clinical guidelines outlining an evidence-based approa

Updated on: February 19,2024

AGA recommends bidirectional endoscopy for most patients with iron deficiency anemia

by American Gastroenterological AssociationCredit: Pixabay/CC0 Public DomainThe American Gastroenterological Association (AGA) published new clinical guidelines outlining an evidence-based approa

Updated on:February 19,2024

FDA approves Skyrizi for moderately to severely active Crohn disease

Skyrizi (risankizumab-rzaa), an interleukin-23 inhibitor, has received U.S. Food and Drug Administration approval to treat moderately to severely active Crohn disease (CD) in adults, according to AbbV

Updated on: February 19,2024

FDA approves Skyrizi for moderately to severely active Crohn disease

Skyrizi (risankizumab-rzaa), an interleukin-23 inhibitor, has received U.S. Food and Drug Administration approval to treat moderately to severely active Crohn disease (CD) in adults, according to AbbV

Updated on:February 19,2024

Colonoscopies in FIT-positive persons require much higher ADR than primary colonoscopy

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study of adults undergoing a colonoscopy after a positive fecal immunochemical testing (FIT) result suggest that endosco

Updated on: February 19,2024

Colonoscopies in FIT-positive persons require much higher ADR than primary colonoscopy

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study of adults undergoing a colonoscopy after a positive fecal immunochemical testing (FIT) result suggest that endosco

Updated on:February 19,2024

Kūmara research offers hope for sleep-deprived parents

by University of AucklandKūmara could be a superior first food for babies, says Professor Clare Wall. Credit: University of AucklandThere's fresh hope for sleep-deprived parents, with a study

Updated on: February 19,2024

Kūmara research offers hope for sleep-deprived parents

by University of AucklandKūmara could be a superior first food for babies, says Professor Clare Wall. Credit: University of AucklandThere's fresh hope for sleep-deprived parents, with a study

Updated on:February 19,2024

AGA releases largest report on safety and effectiveness of fecal microbiota transplantation

byAmerican Gastroenterological AssociationCredit: CC0 Public DomainToday, the American Gastroenterological Association (AGA) released the first results from the NIH-funded AGA Fecal Microbiota T

Updated on: February 19,2024

AGA releases largest report on safety and effectiveness of fecal microbiota transplantation

byAmerican Gastroenterological AssociationCredit: CC0 Public DomainToday, the American Gastroenterological Association (AGA) released the first results from the NIH-funded AGA Fecal Microbiota T

Updated on:February 19,2024

COVID-19 not tied to worse inflammatory bowel disease outcomes

COVID-19 did not have a long-term impact on the disease course of inflammatory bowel disease (IBD), according to a study published online Nov. 4 inTherapeutic Advances in Gastroenterology.Simon

Updated on: February 19,2024

COVID-19 not tied to worse inflammatory bowel disease outcomes

COVID-19 did not have a long-term impact on the disease course of inflammatory bowel disease (IBD), according to a study published online Nov. 4 inTherapeutic Advances in Gastroenterology.Simon

Updated on:February 19,2024

AGA recommends intragastric balloons as an additional weight loss strategy for obese patients

by American Gastroenterological AssociationCredit: CC0 Public DomainObesity is a global pandemic, affecting about 40% of adults in the United States. There is an enormous unmet need for an effect

Updated on: February 19,2024

AGA recommends intragastric balloons as an additional weight loss strategy for obese patients

by American Gastroenterological AssociationCredit: CC0 Public DomainObesity is a global pandemic, affecting about 40% of adults in the United States. There is an enormous unmet need for an effect

Updated on:February 19,2024

Viruses in the guts of centenarians may help them resist pathogens

by Allessandra DiCorato,Broad Institute of MIT and HarvardCredit: Sonja Vasiljeva, Broad CommunicationsNew research suggests that centenarians—people who live to be at least 100—have a diverse c

Updated on: February 19,2024

Viruses in the guts of centenarians may help them resist pathogens

by Allessandra DiCorato,Broad Institute of MIT and HarvardCredit: Sonja Vasiljeva, Broad CommunicationsNew research suggests that centenarians—people who live to be at least 100—have a diverse c

Updated on:February 19,2024

FDA approves Linzess to treat constipation in children, teens

by Lori SolomonThe U.S. Food and Drug Administration approvedLinzess(linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation.The appro

Updated on: February 19,2024

FDA approves Linzess to treat constipation in children, teens

by Lori SolomonThe U.S. Food and Drug Administration approvedLinzess(linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation.The appro

Updated on:February 19,2024

AGA does not recommend the use of probiotics for most digestive conditions

byAmerican Gastroenterological AssociationIt is estimated that more than 3.9 million American adults have taken some form of probiotics, with many patients looking to probiotics to improve their

Updated on: February 19,2024

AGA does not recommend the use of probiotics for most digestive conditions

byAmerican Gastroenterological AssociationIt is estimated that more than 3.9 million American adults have taken some form of probiotics, with many patients looking to probiotics to improve their

Updated on:February 19,2024